CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 58 enrolled
Drug / intervention
iStentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00326014
NCT00326014Phase 4Completed

A Study of the Glaukos Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.

Glaukos Corporation·interventional·Posted May 16, 2006·Updated Jun 8, 2015

In Brief

A Phase 4 clinical trial evaluating iStent for Open-Angle Glaucoma. Completed, enrolled 58 participants across 8 sites in 3 countries.

Detailed Summary

To evaluate the safety and efficacy of a new trabecular bypass that is implanted in conjunction with cataract surgery in open angle glaucoma subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany, Spain, Switzerland
Collaborators--

Timeline

Phase 4CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 16, 2006
Enrollment StartApr 1, 2003
Primary CompletionMar 1, 2008
Study CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 20.1 years ago

Interventions

iStentdevice

Glaucoma Surgery